2025-05-20-Jefferies-杰富瑞前瞻跨行业研究信号_7页_181kb

Equity Research Summary

Macro Outlook

• US Dollar: Coordinated effort with China may lead to prolonged devaluation, boosting export-heavy firms and potentially sparking foreign demand for US goods, prolonging the capex cycle.
• Economic Data: Positive signals from manufacturing and services PMIs; initial jobless claims stable. Leading consensus on 2025 S&P 500 target at 5,300.

Sector Commentary

Positive Drivers:

• US-China Trade Deal: Expected to normalize freight rates, lift costs for FIVE, NKE, SN, YETI. Materials firms like MAS, FBIN to gain from supply chain relief.
• Health Care: Medtech and biotechs (DHR, RGEN) poised for growth due to reduced import tariffs & demand for ad-supported streaming. Nuclear utilities may sign data center deals in weeks.
• Real Estate: Tertiary markets lead 1Q data center leasing volumes, underscoring resilience in infrastructure spending.
• Industrials: Freight rates expected to rise due to trade deal & peak season. MATX seen as top play in logistics.
• TMT: Streamers (NFLX, DIS, AMZN) see user growth, ad revenue expansion, with CRWD’s RIF neutralizing demand concerns.

Overhead Warnings:

• Negative Factors: Supply shock from U.S. outflow of heavy earth magnets; reduced paper mill output easing price pressures only temporarily. Weakest forecasts in durable goods, non-consumer credit trends.

Key Equity Forecasts

• S&P 500 Target: 5,300 (2025) | Russell 2000 Target: 114.92 (2025)
• Jefferies Winners (Buy/Hold):
  • Key Sectors: Biotechs (DHR, RGEN), Retail (NKE), Logistics (MATX), Data Center Enablers (CEG, VST), Digital Content (NFLX, DIS, AMZN).
  • Valuation Focus: Renewable energy (Utility Solar), strengthened post-trades; Nuclear sector under increased tax threat.
• Stop Loss:
  • Avg. Priced < $10 stocks: Hold rated → ±15-20% | Buy rated → ≥15%

Risk Summary

• Importantly rooted in internal Jefferies disclosure; note conflicts of interest for analysts invested in target companies. All performance projections subject to external factors.

*End of Summary; no additional raw data included.*